Microvascular damage in autoimmune connective tissue diseases: a capillaroscopic analysis from 20 years of experience in a EULAR training and research referral centre for imaging
- PMID: 37451812
- PMCID: PMC10351269
- DOI: 10.1136/rmdopen-2023-003071
Microvascular damage in autoimmune connective tissue diseases: a capillaroscopic analysis from 20 years of experience in a EULAR training and research referral centre for imaging
Abstract
Objective: Nailfold videocapillaroscopy (NVC) allows the detection of microvascular damage in autoimmune connective tissue diseases (CTDs). The prevalence of the morphological capillary findings was retrospectively evaluated in a wide cohort of patients with Raynaud's phenomenon secondary to a CTD at the time of the first single NVC, independently from their current treatment, autoantibody profile and comorbidities.
Methods: One-thousand-one-hundred-eighty-one patients affected by CTDs were included from 2001 to 2021. The considered CTDs were systemic sclerosis (SSc), undifferentiated connective tissue disease (UCTD), mixed connective tissue disease (MCTD), dermatomyositis (DM), systemic lupus erythematosus, Sjögren's syndrome and primary antiphospholipid syndrome (aPS). The capillaroscopic parameters were distinguished between scleroderma patterns and non-scleroderma patterns.
Results: Giant capillaries were significantly more frequent in SSc, DM and MCTD than in other CTDs (respectively, in 73%, 73% and 61% of patients, p<0.001 when comparing each rate vs the other CTDs). The mean capillary count was significantly lower in SSc, DM and MCTD (respectively, 7.04±0.18 vs 6.5±0.75 vs 7.7±2 capillaries/linear mm) compared with the other CTDs (p<0.001 for each rate vs the other CTDs). The non-specific abnormalities of capillary morphology were significantly more frequent in SSc, MCTD and aPS (respectively, in 48%, 41% and 36% of cases, all p<0.001 vs each other CTDs).
Conclusion: This large size sample of patients with CTDs, collected over 20 years of analysis, confirms the highest prevalence of specific capillaroscopic alterations in patients with SSc, DM and MCTD, when compared with other CTDs.
Keywords: Sjogren's syndrome; antiphospholipid syndrome; dermatomyositis; lupus erythematosus, systemic; scleroderma, systemic.
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures


Similar articles
-
Capillaroscopic analysis of the microvascular status in mixed versus undifferentiated connective tissue disease.Microvasc Res. 2022 Jul;142:104367. doi: 10.1016/j.mvr.2022.104367. Epub 2022 Mar 29. Microvasc Res. 2022. PMID: 35364109
-
Nailfold capillaroscopy and autoimmune connective tissue diseases in patients from a Portuguese nailfold capillaroscopy clinic.Rheumatol Int. 2020 Feb;40(2):295-301. doi: 10.1007/s00296-019-04427-0. Epub 2019 Aug 26. Rheumatol Int. 2020. PMID: 31451935
-
Clinical applicability of quantitative nailfold capillaroscopy in differential diagnosis of connective tissue diseases with Raynaud's phenomenon.J Formos Med Assoc. 2013 Aug;112(8):482-8. doi: 10.1016/j.jfma.2012.02.029. Epub 2012 Aug 14. J Formos Med Assoc. 2013. PMID: 24016612
-
Nailfold Capillaroscopy - Its Role in Diagnosis and Differential Diagnosis of Microvascular Damage in Systemic Sclerosis.Curr Rheumatol Rev. 2013;9(4):254-60. doi: 10.2174/157339710904140417125241. Curr Rheumatol Rev. 2013. PMID: 26932290 Review.
-
Nailfold capillaroscopy is useful for the diagnosis and follow-up of autoimmune rheumatic diseases. A future tool for the analysis of microvascular heart involvement?Rheumatology (Oxford). 2006 Oct;45 Suppl 4:iv43-6. doi: 10.1093/rheumatology/kel310. Rheumatology (Oxford). 2006. PMID: 16980724 Review.
Cited by
-
Peripheral and ocular microvascular alterations in systemic sclerosis: observations from capillaroscopic assessments, perfusion peripheral analysis, and optical coherence tomography angiography.Rheumatol Int. 2024 Jan;44(1):107-118. doi: 10.1007/s00296-023-05495-z. Epub 2023 Nov 17. Rheumatol Int. 2024. PMID: 37978075 Free PMC article.
-
Multicentre retrospective detection of nailfold videocapillaroscopy abnormalities in long covid patients.RMD Open. 2025 Apr 28;11(2):e005469. doi: 10.1136/rmdopen-2025-005469. RMD Open. 2025. PMID: 40295119 Free PMC article.
-
Increased prevalence of inflammatory arthritis, systemic lupus erythematosus and systemic sclerosis, during 2020-2023 versus 2016-2019 in a Nation-Wide Cohort Study.Rheumatol Int. 2024 Dec;44(12):2837-2846. doi: 10.1007/s00296-024-05733-y. Epub 2024 Oct 8. Rheumatol Int. 2024. PMID: 39375202
-
Improvement of Microangiopathy in A Systemic Sclerosis Patient Following Hysterectomy for Leiomyoma: A Potential Role of Neoplasia.Eur J Case Rep Intern Med. 2025 Mar 26;12(4):005286. doi: 10.12890/2025_005286. eCollection 2025. Eur J Case Rep Intern Med. 2025. PMID: 40270661 Free PMC article.
-
Raynaud's Phenomenon: A Current Update on Pathogenesis, Diagnostic Workup, and Treatment.Vasc Specialist Int. 2024 Jul 23;40:26. doi: 10.5758/vsi.240047. Vasc Specialist Int. 2024. PMID: 39040029 Free PMC article. Review.
References
-
- García-Carrasco M, Sisó A, Ramos-Casals M, et al. . Raynaud’s phenomenon in primary Sjögren’s syndrome. prevalence and clinical characteristics in a series of 320 patients. J Rheumatol 2002;29:726–30. - PubMed
-
- LeRoy EC, Medsger TA. Raynaud’s phenomenon: a proposal for classification. Clin Exp Rheumatol 1992;10:485–8. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous